© Readymade
September 12, 2026
Marianne Waldenfels
Vitamin D, omega-3, and glucosamine are considered staples of healthy aging. But several new studies raise a surprising question: could some supplements affect older adults differently than previously thought?
Find a DoctorSearch the network for suitable specialists and contact them directly
Vitamin D for bones, omega-3 for the brain, glucosamine for the joints — as we get older, many of us turn to these three staples in the hope of staying healthy for as long as possible. Yet within just a few months, several studies have appeared that raise a surprising question about exactly these supplements: Could they actually work differently in the aging brain than we hoped — and under certain circumstances, even unfavorably?
Some of these findings come from observational data, which means they cannot prove cause and effect. Even so, they draw attention to a question that is rarely asked: Is a nutrient that the body needs automatically beneficial when taken as a supplement, and at every stage of life?
It is standard medical practice to adjust medication doses in older patients, because kidney function, metabolism, and body composition all change with age. Strangely, this question is asked far less often when it comes to dietary supplements. Yet the brain's metabolic processes also shift with age — and with them, possibly the conditions under which individual substances have their effects.
This is precisely where the new research steps in. It does not yet show that certain supplements fundamentally behave differently in older age. But it does give us reason to look more closely.
Vitamin D is important for bones and muscles. For years, low vitamin D levels have also been linked to a higher risk of cognitive decline — giving rise to the hope that supplementation might protect the brain as well.
A study published in BMJ Open in 2026 now delivers a surprising result. Researchers analyzed data from 5,065 participants in the US Health and Retirement Study, who were on average 67.5 years old at the start of the study. Around 40 percent were taking vitamin D supplements.
Over six years, overall cognitive performance declined somewhat faster among supplement users than among people who did not take vitamin D. This association also held for executive function — the set of skills that includes planning, problem-solving, and attention.
A sensitivity analysis was particularly telling: the faster decline was seen in people whose vitamin D levels were already within the normal range at the start of the study, but not in those who had low levels.
This distinction matters enormously in practice. The study does not argue against treating a diagnosed vitamin D deficiency. Even in cases of osteoporosis or as part of osteoporosis treatment, maintaining adequate vitamin D levels can be important. What is more questionable is whether supplementing on top of already sufficient levels also benefits cognitive performance.
With few dietary supplements is the connection to brain health as well established as with omega-3. DHA in particular is a key building block of nerve cell membranes. But it does not automatically follow that taking extra fish oil capsules protects the brain from age-related decline.
A 2026 analysis of data from the Alzheimer's Disease Neuroimaging Initiative actually pointed in the opposite direction: older adults who took omega-3 supplements showed faster cognitive decline on three different test scales than comparable individuals who did not supplement.
Why this is the case cannot be determined from the study alone. Neither amyloid deposits, tau proteins, nor loss of gray matter appeared to account for the observed difference. What did stand out, however, was a more pronounced decline in glucose metabolism in the brain regions most affected by Alzheimer's disease.
The study has not gone unchallenged. A subsequently published scientific commentary pointed out several methodological limitations. For one, the data only captured omega-3 intake to a limited degree, with no detailed information on dosage, composition, or supplement quality. Reverse causality is also possible: some participants may have begun taking omega-3 precisely because they had noticed early memory problems.
Glucosamine is the furthest removed from its expected area of application. The substance is used primarily for joint complaints and osteoarthritis and is not normally associated with the brain at all.
A study published in Nature Metabolism in 2026 examined a metabolic process called glycosylation, in which certain sugar structures are attached to proteins and other molecules. The researchers found indications that this process may be altered in the brains of people with Alzheimer's disease.
In an animal model, mice with Alzheimer's were given glucosamine at a dose based on typical supplement amounts. Their memory performance worsened. In healthy mice, however, the same effect was not observed.
The team then analyzed large amounts of patient data, including around 25,000 people with Alzheimer's and 42,000 with mild cognitive impairment (MCI). Among people with MCI, documented glucosamine use was more frequently associated with progression to Alzheimer's dementia. In people who already had dementia, an association with higher mortality was also observed.
This data is not sufficient to issue a warning against glucosamine. The findings in humans come from retrospective observations, in which other health factors may well have played a role. The results are most notable for people with pre-existing cognitive impairment or dementia. Whether the mechanism identified in the laboratory is actually relevant in humans will need to be established by further research.
No one should stop taking any of these supplements across the board. The distinction is especially important for vitamin D: a diagnosed deficiency or a medically justified prescription — such as in the context of osteoporosis treatment — is a very different situation from taking supplements as a precaution when levels are already adequate.
For omega-3 and glucosamine as well, the new data are not enough to support blanket recommendations. Anyone taking one of these supplements for medical reasons should not change their intake on their own on the basis of these studies.
The real significance of these new studies is not that three familiar supplements have suddenly been deemed harmful. Rather, they challenge an assumption that has underpinned the supplement boom for years: that a substance the body needs, or that is beneficial in certain situations, will automatically deliver even greater benefit when taken as an additional dose.
When it comes to healthy aging in particular, a different question may therefore matter more than the search for the next supposed longevity supplement — not "What else should I be taking?" but "What do I actually need?"
Better sperm through biohacking? That's exactly what the trend known as "spermmaxxing" promises. Urologist Dr. Daniel Kaminski explains which methods fall short — and what can actually influence sperm quality.
Christine Bürg & Marianne Waldenfels
With
Dr. med. Daniel Kaminski
Falling asleep with earbuds and leaving them in until morning? ENT physician Dr. Kristina Wiedelmann-Breloer is seeing more patients with ear canal inflammation and eczema linked to their use. She explains what can happen inside the ear overnight — and how to reduce the risks.
Christine Bürg & Marianne Waldenfels
With
Kristina Wiedelmann-Breloer
